ALX Oncology Holdings Inc
COMMON · CUSIP 01166B105
1
institutional holders
+0 vs Q1 2021
3.2k
shares reported held*
$175.0kreported value*
0 new
0 added
0 reduced
0 sold out
net bought ≈ $0
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $54.69.
Trends to Q2 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2021 | 1 |
| Q2 2021 | 1 |
Holders, Q2 2021
| Manager | Shares | Change |
|---|---|---|
| Knott David M 0.06% of their portfolio | 3.2k $175.0k | Unchanged |